Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

158 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Practitioner Review: Current best practice in the use of parent training and other behavioural interventions in the treatment of children and adolescents with attention deficit hyperactivity disorder.
Daley D, Van Der Oord S, Ferrin M, Cortese S, Danckaerts M, Doepfner M, Van den Hoofdakker BJ, Coghill D, Thompson M, Asherson P, Banaschewski T, Brandeis D, Buitelaar J, Dittmann RW, Hollis C, Holtmann M, Konofal E, Lecendreux M, Rothenberger A, Santosh P, Simonoff E, Soutullo C, Steinhausen HC, Stringaris A, Taylor E, Wong ICK, Zuddas A, Sonuga-Barke EJ. Daley D, et al. Among authors: santosh p. J Child Psychol Psychiatry. 2018 Sep;59(9):932-947. doi: 10.1111/jcpp.12825. Epub 2017 Oct 30. J Child Psychol Psychiatry. 2018. PMID: 29083042 Review.
Stimulant drugs.
Santosh PJ, Taylor E. Santosh PJ, et al. Eur Child Adolesc Psychiatry. 2000;9 Suppl 1:I27-43. doi: 10.1007/s007870070017. Eur Child Adolesc Psychiatry. 2000. PMID: 11140778 Review.
Non-stimulant medications in the treatment of ADHD.
Banaschewski T, Roessner V, Dittmann RW, Santosh PJ, Rothenberger A. Banaschewski T, et al. Eur Child Adolesc Psychiatry. 2004;13 Suppl 1:I102-16. doi: 10.1007/s00787-004-1010-x. Eur Child Adolesc Psychiatry. 2004. PMID: 15322961 Review.
Symptom control in children and adolescents with attention-deficit/hyperactivity disorder on switching from immediate-release MPH to OROS MPH Results of a 3-week open-label study.
Remschmidt H, Hoare P, Ettrich C, Rothenberger A, Santosh P, Schmidt M, Spender Q, Tamhne R, Thompson M, Tinline C, Trott GE, Medori R. Remschmidt H, et al. Among authors: santosh p. Eur Child Adolesc Psychiatry. 2005 Sep;14(6):297-304. doi: 10.1007/s00787-005-0467-6. Eur Child Adolesc Psychiatry. 2005. PMID: 16220213 Clinical Trial.
12-month efficacy and safety of OROS MPH in children and adolescents with attention-deficit/hyperactivity disorder switched from MPH.
Hoare P, Remschmidt H, Medori R, Ettrich C, Rothenberger A, Santosh P, Schmit M, Spender Q, Tamhne R, Thompson M, Tinline C, Trott GE. Hoare P, et al. Among authors: santosh p. Eur Child Adolesc Psychiatry. 2005 Sep;14(6):305-9. doi: 10.1007/s00787-005-0486-3. Eur Child Adolesc Psychiatry. 2005. PMID: 16220214 Clinical Trial.
Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline.
Banaschewski T, Coghill D, Santosh P, Zuddas A, Asherson P, Buitelaar J, Danckaerts M, Döpfner M, Faraone SV, Rothenberger A, Sergeant J, Steinhausen HC, Sonuga-Barke EJ, Taylor E. Banaschewski T, et al. Among authors: santosh p. Eur Child Adolesc Psychiatry. 2006 Dec;15(8):476-95. doi: 10.1007/s00787-006-0549-0. Epub 2006 May 5. Eur Child Adolesc Psychiatry. 2006. PMID: 16680409 Review.
158 results